RIVZEPRI
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Oct 2025)
What this means for you
This application is over — abandoned 07 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97274856
- Mark type
- Stylized text
- Filed
- 18 Feb 2022
- Published for opposition
- 07 Nov 2023
- Abandoned
- 07 Oct 2025
- Attorney of record
- Harold Milstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of chronic fibrotic and proliferative disorders; pharmaceutical preparations for the treatment of cancer, muscular dystrophy and idiopathic pulmonary fibrosis
Owner
- FibroGen, Inc., San Francisco, CA, US
- FibroGen, Inc., San Francisco, CA, US
Prosecution history
- 07 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 07 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Oct 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Oct 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 18 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2024 — SOU EXTENSION 1 GRANTED
- 18 Jun 2024 — SOU EXTENSION 1 FILED
- 18 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 02 Jan 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Nov 2023 — PUBLISHED FOR OPPOSITION
- 18 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Aug 2023 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED